Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer.

导出 LinkOut

翻译打印收藏纠错

作者： Daniele,Lavacchi ^[1] ; Sara,Fancelli ^[1] ; Giandomenico,Roviello ^[2] ; Francesca,Castiglione ^[3] ; Enrico,Caliman ^[4] ; Gemma,Rossi ^[1] ; Jacopo,Venturini ^[2] ; Elisa,Pellegrini ^[1] ; Marco,Brugia ^[1] ; Agnese,Vannini ^[5] ; Caterina,Bartoli ^[5] ; Fabio,Cianchi ^[1] ; Serena,Pillozzi ^[4] ; Lorenzo,Antonuzzo ^[2]

作者单位： Clinical Oncology Unit, Careggi University Hospital, Florence, Italy. ^[1] Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. ^[2] Department of Health Science, University of Florence, Florence, Italy. ^[3] Pathologic Histology and Molecular diagnostic Unit, Careggi University Hospital, Florence, Italy. ^[4] Medical Oncology Unit, Careggi University Hospital, Florence, Italy. ^[5]

关键词 Exon 4 G12C G12V KRAS bevacizumab codon 117 codon 146 colorectal cancer

DOI 10.3389/fonc.2022.1055019

PMID 36523988

发布时间 2022-12-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in oncology

2022年12卷

1055019页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除